| Trial ID: | L0521 |
| Source ID: | IRCT2017102537007N1
|
| Associated Drug: |
Probiotic
|
| Title: |
Effect of probiotic in improving laboratory findings in nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease (NAFLD). <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: In intervention group, two Gerilact tablets 500 mg will be administered daily for 60 days. Intervention 2: In control group, two placebo tablets will be given daily for 60 days.;Treatment - Drugs;Placebo;In intervention group, two Gerilact
|
| Outcome Measures: |
Lipid profile. Timepoint: Before and at the end of intervention. Method of measurement: with laboratory examination.;Liver function tests. Timepoint: Before and at the end of intervention. Method of measurement: with laboratory examination.;Fatty liver grade. Timepoint: Before and at the end of intervention. Method of measurement: With sonography.nan
|
| Sponsor/Collaborators: |
Vice chancellor for research, Ardabil University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 yearsno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
12/11/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/27500
|
